In a pediatric first aid/CPR/AED course, participants learn how to prevent, recognize and respond to cardiac and breathing emergencies, use an automatic external defibrillator (AED), treat wounds and burns, and care for sudden illnesses in infants and children under age 12.
Montelukast (trade names Singulair, Montelo-10, and Monteflo and Lukotas in India, Arokast in Bangladesh and Pulmikast in Pakistan) is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.ontelukast is a CysLT1 antagonist; it blocks the action of leukotriene D4 (and secondary ligands LTC4 and LTE4) on the cysteinyl leukotriene receptor CysLT 1 in the lungs and bronchial tubes by binding to it.
Therefore, unlike zafirlukast, montelukast is not expected to affect the elimination of other drugs. The safety and effectiveness of montelukast has been demonstrated in children as young as 6 months of age. It was approved by the FDA in 1998.